Tuesday, March 11, 2014 9:50:55 AM
CMXI 0.52 OTC-stock but probably good time to get in the next few days. catalysts in may are coming nearer.
$heff did some nice DD on it and he has a decent track record in finding diamonds in the rough. He rarely covers OTC-stocks, so for this one he must be really confident. The following is $heffs DD:
The company is a fully reporting pink sheet company that deserves some attention here due to the recent changes to Medicare payment system change for Wound Care Products in 2014. Center for Medicare Services and their favorable reimbursement for Autologel will put this company back on the map in 2014.
Here is the company website.
http://www.cytomedix.com/
Share Structure is 105m shares O/S and 59M shares in the float. http://finance.yahoo.com/q/ks?s=CMXI+Key+Statistics
Market cap is only 60m.
The company also has a strong catalyst in May that could be very significant for the company.
$CMXI Announces Completion of RECOVER-Stroke Trial Enrollment Top Line Data Expected in May '14. http://finance.yahoo.com/news/cytomedix-announces-completion-recover-stroke-130000663.html?soc_src=mediacontentstory …
May Catalyst Clinical Trial Site on ALD-401.
http://clinicaltrials.gov/ct2/show/NCT01273337
The stock is covered by Zacks Analyst, Jason Napodano. His JP Morgan Healthcare Meeting Notes on http://seekingalpha.com/article/1961971-notes-from-one-on-one-meetings-during-san-fran-biotech-week-day-1 …
http://seekingalpha.com/article/1757332-big-changes-coming-to-the-wound-care-market-in-2014?source=kizur_tw
CMXI..2014 Product Presentation at JP Morgan Conf.
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=9705212
April 17th, 2013 CMXI Presentation-REGENMED Investor Day
Big Changes Coming To The Wound Care Market In 2014 [Cytomedix, Inc.,] -Seeking Alpha http://bit.ly/1gcrxZV
Q3 2013 Earnings..shift is moving to Autologel in anticipation of Medicare Decision
http://www.cytomedix.com/Portals/121782/docs/20131112-CMXI-3Q13-Earnings-Release-FINAL.pdf
Medicare Decision on Dec 1st, 2013
http://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/Autologous-Platelet-rich-Plasma-PRP.html
http://www.cytomedix.com/reimbursement/
$heff did some nice DD on it and he has a decent track record in finding diamonds in the rough. He rarely covers OTC-stocks, so for this one he must be really confident. The following is $heffs DD:
The company is a fully reporting pink sheet company that deserves some attention here due to the recent changes to Medicare payment system change for Wound Care Products in 2014. Center for Medicare Services and their favorable reimbursement for Autologel will put this company back on the map in 2014.
Here is the company website.
http://www.cytomedix.com/
Share Structure is 105m shares O/S and 59M shares in the float. http://finance.yahoo.com/q/ks?s=CMXI+Key+Statistics
Market cap is only 60m.
The company also has a strong catalyst in May that could be very significant for the company.
$CMXI Announces Completion of RECOVER-Stroke Trial Enrollment Top Line Data Expected in May '14. http://finance.yahoo.com/news/cytomedix-announces-completion-recover-stroke-130000663.html?soc_src=mediacontentstory …
May Catalyst Clinical Trial Site on ALD-401.
http://clinicaltrials.gov/ct2/show/NCT01273337
The stock is covered by Zacks Analyst, Jason Napodano. His JP Morgan Healthcare Meeting Notes on http://seekingalpha.com/article/1961971-notes-from-one-on-one-meetings-during-san-fran-biotech-week-day-1 …
http://seekingalpha.com/article/1757332-big-changes-coming-to-the-wound-care-market-in-2014?source=kizur_tw
CMXI..2014 Product Presentation at JP Morgan Conf.
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=9705212
April 17th, 2013 CMXI Presentation-REGENMED Investor Day
Big Changes Coming To The Wound Care Market In 2014 [Cytomedix, Inc.,] -Seeking Alpha http://bit.ly/1gcrxZV
Q3 2013 Earnings..shift is moving to Autologel in anticipation of Medicare Decision
http://www.cytomedix.com/Portals/121782/docs/20131112-CMXI-3Q13-Earnings-Release-FINAL.pdf
Medicare Decision on Dec 1st, 2013
http://www.cms.gov/Medicare/Coverage/Coverage-with-Evidence-Development/Autologous-Platelet-rich-Plasma-PRP.html
http://www.cytomedix.com/reimbursement/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
